AI-Enabled Target Discovery Platform for Autoimmune Disease Research
In healthcare and biopharma, the challenge is rarely a lack of data - it is the ability to turn that data into actionable clinical and research insights. This case study shows how Langate helped a global immunology-focused biopharmaceutical company improve target discovery for rheumatoid arthritis by combining biomedical data integration with AI-driven analysis.
Summary
Langate implemented an AI-powered platform that connected multi-omics data, clinical evidence, and market insights into a unified target discovery workflow.
Quick Facts
- Timeline: 8 months
- Team: 7+ specialists (incl. client-side experts)
- Output: 18 validated target candidates
- 60%+ faster target prioritization
- Improved cross-team collaboration in R&D
Project Scope
The project covered full-cycle development, from data integration and ontology mapping to model validation and visualization. The focus was on enabling real-world usability for research and strategy teams within a regulated healthcare environment.
Tech Stack
- Python
- PyTorch
- Vertex AI
- Spotfire
- REST APIs
Data sources: OpenTargets, TCGA, ChEMBL, GWAS Catalog, Pharmaproject, BioTuring, PubMed
The Client
The client is a global biopharmaceutical organization specializing in immunology and autoimmune diseases. They aimed to accelerate the discovery of therapeutic targets for rheumatoid arthritis while improving the quality and consistency of decision-making across R&D teams.
Business Requirements
- Accelerate early-stage drug discovery workflows
- Improve reliability of target selection
- Combine clinical, biological, and market perspectives
- Ensure compliance with data governance standards
- Enable collaboration across research and business units
The Problem
Despite having access to large volumes of biomedical data, the client lacked a unified system to interpret it. Target discovery relied heavily on manual analysis and disconnected tools, which slowed down research and increased the risk of missing promising candidates.
The Challenges
-
Working with complex biomedical datasets across multiple domains - Ensuring clinical relevance of AI-generated insights
- Aligning outputs with regulatory and research standards
- Integrating new tools into existing R&D workflows without disruption
Problems Revealed
The project uncovered a deeper issue: data existed, but it was not connected in a way that supported clinical decision-making. Research, validation, and commercial assessment operated in silos, limiting the overall effectiveness of the discovery process.
The Solution
Achievements
-
18 high-confidence targets identified
-
Over 60% reduction in time required for target selection
-
Improved collaboration between scientific and business teams
-
More consistent and evidence-based prioritization
The platform strengthened the client’s ability to move from research data to actionable clinical insights.
Future Plans
-
The client is expanding the platform to additional disease areas and exploring its use in downstream processes such as compound design.
-
Langate continues to support the evolution of the system toward a fully integrated AI-assisted discovery environment.
Don’t wait - enhance your software’s performance.
Send a message to Langate sales
